Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients

Creative Commons License

Gunel N., Coskun U., Sancak B., Gunel U., Hasdemir O., Bozkurt S.

CANCER, cilt.95, sa.3, ss.663-667, 2002 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 95 Sayı: 3
  • Basım Tarihi: 2002
  • Doi Numarası: 10.1002/cncr.10705
  • Dergi Adı: CANCER
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.663-667
  • Anahtar Kelimeler: IL-18, serum, breast carcinoma, nitrate and nitrite, bone, nitric oxide, GAMMA-INDUCING FACTOR, INTERFERON-GAMMA, BONE METASTASIS, EXPRESSION, CANCER, SYNTHASE, IL-18, INHIBITION, CLONING, CELLS
  • Gazi Üniversitesi Adresli: Evet

Özet

BACKGROUND. Interleukin-18 (IL-18) is a novel immunoregulatory cytokine that was known previously as interferon-gamma-inducing factor. IL-18 levels can be used as a serum indicator for monitoring the clinical course of patients with hematologic malignancies and gastric carcinoma. Nitric oxide (NO) is a pleiotropic molecule that participates in the multistep processing of carcinogenesis.